Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review Article
  • Published:

Peritoneal dialysis in children with end-stage renal disease

Abstract

Peritoneal dialysis is the preferred chronic dialysis modality for most children owing to its almost universal applicability and superior compatibility with lifestyle over other modalities. Although technological advances and increasing clinical experience have impacted favorably on patient and technique survival, clinical research in pediatric peritoneal dialysis has been hampered by the low incidence of end-stage renal disease (ESRD) in the pediatric population. To overcome this limitation, several international registries have emerged in the past few years to complement other long-standing registries, which together have provided useful information regarding technique-specific complications and comorbidities associated with ESRD in children undergoing chronic peritoneal dialysis. In this Review, we summarize the most relevant findings from these studies, highlighting the substantial variation in patient conditions, peritoneal dialysis practices and management of comorbidities encountered in different parts of the world.

Key Points

  • Infection, ultrafiltration failure and adhesions are the most common causes of technique failure in children receiving peritoneal dialysis

  • Marked regional variation exists regarding the spectrum and antibiotic susceptibility patterns of bacteria causing peritonitis associated with peritoneal dialysis in children

  • The prevalence of hyperphosphatemia, severe hyperparathyroidism and bone disease in children on peritoneal dialysis shows marked global variation, being highest in the Americas and lowest in Asia and Europe

  • Early enteral feeding improves weight gain and can cause obesity in infants on peritoneal dialysis, but its efficacy in preventing growth failure is limited

  • Arterial hypertension is present in two-thirds of children undergoing chronic peritoneal dialysis and uncontrolled hypertension in one-third of these children

  • Left ventricular hypertrophy is present in 50% of children undergoing chronic peritoneal dialysis; fluid overload, hypertension and hyperparathyroidism are the most important risk factors for left ventricular hypertrophy

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Distribution of peritonitis culture results according to geographical regions.
Figure 2: Variation in the control of iPTH levels by country.
Figure 3: Percentage of patients with alterations of bone and mineral metabolism stratified by time-averaged mean PTH levels.
Figure 4: Time-averaged mean plasma iPTH concentrations and change in standardized height.
Figure 5: LVMI in 507 children receiving chronic peritoneal dialysis followed in the International Pediatric Peritoneal Dialysis Network Registry.

Similar content being viewed by others

References

  1. Harambat, J., van Stralen, K. J., Kim, J. J. & Tizard, E. J. Epidemiology of chronic kidney disease in children. Pediatr. Nephrol. http://dx.doi.org/10.1007/s00467-011-1939-1.

  2. International Pediatric Peritoneal Dialysis Network. About IPPN [online], (2011).

  3. North American Pediatric Renal Trials and Collaborative Studies. NAPRTCS 2011 Annual Dialysis Report [online], (2011).

  4. National Kidney Foundation. KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for 2006 Updates. Hemodialysis Adequacy, Peritoneal Dialysis Adequacy, Vascular Access. Am. J. Kidney Dis. 48 (Suppl. 1), S1–S322 (2006).

  5. Warady, B. A., Alexander, S. R., Watkins, S., Kohaut, E. & Harmon, W. E. Optimal care of the pediatric end-stage renal disease patient on dialysis. Am. J. Kidney Dis. 33, 567–583 (1999).

    Article  CAS  Google Scholar 

  6. Hari, P. et al. Chronic renal failure in children. Indian Pediatr. 40, 1035–1042 (2003).

    PubMed  Google Scholar 

  7. Wang, T. & Wan, H. Y. Peritoneal dialysis in China: problem and prospects [Chinese]. Chin. J. Intern. Med. 42, 757–759 (2003).

    Google Scholar 

  8. Xu, H. & Bagga, A. in Pediatric Dialysis 2nd edn (eds Warady, B. A., Schaefer, F. & Alexander, S. R.) (Springer, in press).

  9. Alexander, S. R., Salusky, I. B., Warady, B. A. & Watkins, S. L. Peritoneal dialysis workshop: pediatrics recommendations. Perit. Dial. Int. 17 (Suppl. 3), S25–S27 (1997).

    PubMed  Google Scholar 

  10. Salusky, I. B. & Holloway, M. Selection of peritoneal dialysis for pediatric patients. Perit. Dial. Int. 17 (Suppl. 3), S35–S37 (1997).

    PubMed  Google Scholar 

  11. Warady, B. A., Schaefer, F., Alexander, S. R., Firanek, C. & Mujais, S. in Care of the pediatric patient on peritoneal dialysis: clinical process for optimal outcomes (brochure). (Baxter Healthcare Corporation, McGaw Park, 2004).

    Google Scholar 

  12. Al-Hermi, B. E., Al-Saran, K., Secker, D. & Geary, D. F. Hemodialysis for end-stage renal disease in children weighing less than 10 kg. Pediatr. Nephrol. 13, 401–403 (1999).

    Article  CAS  Google Scholar 

  13. Kovalski, Y., Cleper, R., Kruse, I. & Davidovits, M. Hemodialysis in children weighing less than 15 kg: a single-center experience. Pediatr. Nephrol. 22, 2105–2110 (2007).

    Article  Google Scholar 

  14. Eisenstein, I. et al. Low infection rates and prolonged survival times of hemodialysis catheters in infants and children. Clin. J. Am. Soc. Nephrol. 6, 793–798 (2011).

    Article  Google Scholar 

  15. Wisanuyotin, S. et al. Complications of peritoneal dialysis in children with Eagle-Barrett syndrome. Pediatr. Nephrol. 18, 159–163 (2003).

    PubMed  Google Scholar 

  16. Honda, M. & Warady, B. A. Long-term peritoneal dialysis and encapsulating peritoneal sclerosis in children. Pediatr. Nephrol. 25, 75–81 (2010).

    Article  Google Scholar 

  17. Verrina, E. et al. A multicenter experience on patient and technique survival in children on chronic dialysis. Pediatr. Nephrol. 19, 82–90 (2004).

    Article  Google Scholar 

  18. Vidal, E. et al. on behalf of Italian Registry of Paediatric Chronic Dialysis. Peritoneal dialysis in infants: the experience of the Italian Registry of Paediatric Chronic Dialysis. Nephrol. Dial. Transplant. http://dx.doi.org/10.1093/ndt/gfr322.

  19. US Renal Data System. USRDS 2009 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States [online], (2009).

  20. McDonald, S. P. & Craig, J. C. for the Australian and New Zealand Paediatric Nephrology Association. Long-term survival of children with end-stage renal disease. N. Engl. J. Med. 350, 2654–2662 (2004).

    Article  CAS  Google Scholar 

  21. Chadha, V., Schaefer, F. S. & Warady, B. A. Dialysis-associated peritonitis in children. Pediatr. Nephrol. 25, 425–440 (2010).

    Article  Google Scholar 

  22. US Renal Data System. USRDS 2007 Annual Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States [online], (2007).

  23. Bordador, E. B. et al. on behalf of the Australian and New Zealand Dialysis and Transplant Registry. Epidemiology and outcomes of peritonitis in children on peritoneal dialysis in Australasia. Pediatr. Nephrol. 25, 1739–1745 (2010).

    Article  Google Scholar 

  24. Zelenitsky, S. et al. Analysis of microbiological trends in peritoneal dialysis-related peritonitis from 1991 to 1998. Am. J. Kidney Dis. 36, 1009–1013 (2000).

    Article  CAS  Google Scholar 

  25. Piraino, B., Bernardini, J., Florio, T. & Fried, L. Staphylococcus aureus prophylaxis and trends in gram-negative infections in peritoneal dialysis patients. Perit. Dial. Int. 23, 456–459 (2003).

    PubMed  Google Scholar 

  26. Warady, B. A. et al. for the International Pediatric Peritonitis Registry (IPPR). Peritonitis in children who receive long-term peritoneal dialysis: a prospective evaluation of therapeutic guidelines. J. Am. Soc. Nephrol. 18, 2172–2179 (2007).

    Article  Google Scholar 

  27. Schaefer, F. et al. Worldwide variation of dialysis-associated peritonitis in children. Kidney Int. 72, 1374–1379 (2007).

    Article  CAS  Google Scholar 

  28. Piraino, B. et al. for the ISPD Ad Hoc Advisory Committee. Peritoneal dialysis-related infections recommendations: 2005 update. Perit. Dial. Int. 25, 107–131 (2005).

    PubMed  Google Scholar 

  29. Li, P. K. et al. Peritoneal dialysis-related infections recommendations: 2010 update. Perit. Dial. Int. 30, 393–423 (2010).

    Article  Google Scholar 

  30. Warady, B. A., Hébert, D., Sullivan, E. K., Alexander, S. R. & Tejani, A. Renal transplantation, chronic dialysis, and chronic renal insufficiency in children and adolescents. The 1995 Annual Report of the North American Pediatric Renal Transplant Cooperative Study. Pediatr. Nephrol. 11, 49–64 (1997).

    Article  CAS  Google Scholar 

  31. Furth, S. L., Donaldson, L. A., Sullivan, E. K. & Watkins, S. L. for the North American Pediatric Renal Transplant Cooperative Study. Peritoneal dialysis catheter infections and peritonitis in children: a report of the North American Pediatric Renal Transplant Cooperative Study. Pediatr. Nephrol. 15, 179–182 (2000).

    Article  CAS  Google Scholar 

  32. Warady, B. A. et al. for the International Society for Peritoneal Dialysis (ISPD) Advisory Committee on Peritonitis Management in Pediatric Patients. Consensus guidelines for the treatment of peritonitis in pediatric patients receiving peritoneal dialysis. Perit. Dial. Int. 20, 610–624 (2000).

    CAS  PubMed  Google Scholar 

  33. von Schnakenburg, C. et al. Percutaneous endoscopic gastrostomy in children on peritoneal dialysis. Perit. Dial. Int. 26, 69–77 (2006).

    PubMed  Google Scholar 

  34. Bernardini, J., Price, V. & Figueiredo, A. for the International Society for Peritoneal Dialysis (ISPD) Nursing Liaison Committee. Peritoneal dialysis patient training, 2006. Perit. Dial. Int. 26, 625–632 (2006).

    PubMed  Google Scholar 

  35. Bernardini, J., Price, V., Figueiredo, A., Riemann, A. & Leung, D. International survey of peritoneal dialysis training programs. Perit. Dial. Int. 26, 658–663 (2006).

    PubMed  Google Scholar 

  36. Adderson, E. E., Flynn, P. M. & Hoffman, J. M. Efficacy and safety of cefepime in pediatric patients: a systematic review and meta-analysis. J. Pediatr. 157, 490–495 (2010).

    Article  CAS  Google Scholar 

  37. Rinaldi, S. et al. for the Italian Registry of Pediatric Chronic Peritoneal Dialysis. Chronic peritoneal dialysis catheters in children: a fifteen-year experience of the Italian Registry of Pediatric Chronic Peritoneal Dialysis. Perit. Dial. Int. 24, 481–486 (2004).

    PubMed  Google Scholar 

  38. Aksu, N. et al. A ten-year single-centre experience in children on chronic peritoneal dialysis—significance of percutaneous placement of peritoneal dialysis catheters. Nephrol. Dial. Transplant. 22, 2045–2051 (2007).

    Article  Google Scholar 

  39. Bernardini, J. et al. Randomized, double-blind trial of antibiotic exit site cream for prevention of exit site infection in peritoneal dialysis patients. J. Am. Soc. Nephrol. 16, 539–545 (2005).

    Article  CAS  Google Scholar 

  40. Chua, A. N., Goldstein, S. L., Bell, D. & Brewer, E. D. Topical mupirocin/sodium hypochlorite reduces peritonitis and exit-site infection rates in children. Clin. J. Am. Soc. Nephrol. 4, 1939–1943 (2009).

    Article  Google Scholar 

  41. Warady, B. A. et al. Peritoneal membrane transport function in children receiving long-term dialysis. J. Am. Soc. Nephrol. 7, 2385–2391 (1996).

    CAS  PubMed  Google Scholar 

  42. Twardowski, Z. et al. Peritoneal equilibration test. Perit. Dial. Bull. 7, 138–147 (1986).

    Google Scholar 

  43. Schaefer, F., Langenbeck, D., Heckert, K., Schärer, K. & Mehls, O. Evaluation of peritoneal solute transfer by the peritoneal equilibration test in children. Adv. Perit. Dial. 8, 410–415 (1992).

    CAS  PubMed  Google Scholar 

  44. Kohaut, E. C., Waldo, F. B. & Benfield, M. R. The effect of changes in dialysate volume on glucose and urea equilibration. Perit. Dial. Int. 14, 236–239 (1994).

    CAS  PubMed  Google Scholar 

  45. de Boer, A. W. et al. The necessity of adjusting dialysate volume to body surface area in pediatric peritoneal equilibration tests. Perit. Dial. Int. 17, 199–202 (1997).

    CAS  PubMed  Google Scholar 

  46. Haraldsson, B. Assessing the peritoneal dialysis capacities of individual patients. Kidney Int. 47, 1187–1198 (1995).

    Article  CAS  Google Scholar 

  47. Bouts, A. H. et al. Standard peritoneal permeability analysis in children. J. Am. Soc. Nephrol. 11, 943–950 (2000).

    CAS  PubMed  Google Scholar 

  48. Fischbach, M. & Warady, B. A. Peritoneal dialysis prescription in children: bedside principles for optimal practice. Pediatr. Nephrol. 24, 1633–1642 (2009).

    Article  Google Scholar 

  49. Fischbach, M., Stefanidis, C. J. & Watson, A. R. for the European Pediatric Peritoneal Dialysis Working Group. Guidelines by an ad hoc European committee on adequacy of the paediatric peritoneal dialysis prescription. Nephrol. Dial. Transplant. 17, 380–385 (2002).

    Article  Google Scholar 

  50. Fischbach, M. & Haraldsson, B. Dynamic changes of the total pore area available for peritoneal exchange in children. J. Am. Soc. Nephrol. 12, 1524–1529 (2001).

    CAS  PubMed  Google Scholar 

  51. Fischbach, M. et al. Measurement of hydrostatic intraperitoneal pressure: a useful tool for the improvement of dialysis dose prescription. Pediatr. Nephrol. 18, 976–980 (2003).

    Article  CAS  Google Scholar 

  52. Fadrowski, J. J. et al. Children on long-term dialysis in the United States: findings from the 2005 ESRD Clinical Performance Measures Project. Am. J. Kidney Dis. 50, 958–966 (2007).

    Article  CAS  Google Scholar 

  53. Morgenstern, B. Z., Mahoney, D. W. & Warady, B. A. Estimating total body water in children on the basis of height and weight: a reevaluation of the formulas of Mellits and Cheek. J. Am. Soc. Nephrol. 13, 1884–1888 (2002).

    Article  Google Scholar 

  54. Blake, P. G. et al. for the Canadian Society of Nephrology Work Group on Adequacy of Peritoneal Dialysis. Clinical practice guidelines and recommendations on peritoneal dialysis adequacy 2011. Perit. Dial. Int. 31, 218–239 (2011).

    PubMed  Google Scholar 

  55. Borzych, D. et al. for the International Pediatric PD Network (IPPN). The bone and mineral disorder of children undergoing chronic peritoneal dialysis. Kidney Int. 78, 1295–1304 (2010).

    Article  Google Scholar 

  56. Klaus, G. et al. for the European Pediatric Dialysis Working Group (EPDWG). Prevention and treatment of renal osteodystrophy in children on chronic renal failure: European guidelines. Pediatr. Nephrol. 21, 151–159 (2006).

    Article  CAS  Google Scholar 

  57. National Kidney Foundation. K/DOQI clinical practice guidelines for bone metabolism and disease in children with chronic kidney disease. Am. J. Kidney Dis. 46 (Suppl. 1), 12–100 (2005).

  58. Waller, S., Shroff, R., Freemont, A. J. & Rees, L. Bone histomorphometry in children prior to commencing renal replacement therapy. Pediatr. Nephrol. 23, 1523–1529 (2008).

    Article  Google Scholar 

  59. Ledermann, S. E., Spitz, L., Moloney, J., Rees, L. & Trompeter, R. S. Gastrostomy feeding in infants and children on peritoneal dialysis. Pediatr. Nephrol. 17, 246–250 (2002).

    Article  Google Scholar 

  60. Rees, L. et al. for the International Pediatric Peritoneal Dialysis Network. Factors affecting growth in infants undergoing chronic peritoneal dialysis. J. Am. Soc. Nephrol. (in press).

  61. Rabkin, R., Sun, D. F., Chen, Y., Tan, J. & Schaefer, F. Growth hormone resistance in uremia, a role for impaired JAK/STAT signaling. Pediatr. Nephrol. 20, 313–318 (2005).

    Article  Google Scholar 

  62. Schaefer, F., Chen, Y., Tsao, T., Nouri, P. & Rabkin, R. Impaired JAK-STAT signal transduction contributes to growth hormone resistance in chronic uremia. J. Clin. Invest. 108, 467–475 (2001).

    Article  CAS  Google Scholar 

  63. Haffner, D. et al. for the German Study Group for Growth Hormone Treatment in Chronic Renal Failure. Factors predictive of the short- and long-term efficacy of growth hormone treatment in prepubertal children with chronic renal failure. J. Am. Soc. Nephrol. 9, 1899–1907 (1998).

    CAS  PubMed  Google Scholar 

  64. Schaefer, F., Wühl, E., Haffner, D. & Mehls, O. for the German Study Group for Growth Hormone Treatment in Chronic Renal Failure. Stimulation of growth by recombinant human growth hormone in children undergoing peritoneal dialysis or hemodialysis treatment. Adv. Perit. Dial. 10, 321–326 (1994).

    CAS  PubMed  Google Scholar 

  65. Wühl, E., Haffner, D., Nissel, R., Schaefer, F. & Mehls, O. Short dialyzed children respond less to growth hormone than patients prior to dialysis. German Study Group for Growth Hormone Treatment in Chronic Renal Failure. Pediatr. Nephrol. 10, 294–298 (1996).

    Article  Google Scholar 

  66. Bérard, E. et al. Recombinant human growth hormone treatment of children on hemodialysis. French Society of Pediatric Nephrology. Pediatr. Nephrol. 12, 304–310 (1998).

    Article  Google Scholar 

  67. Chadha, V., Blowey, D. L. & Warady, B. A. Is growth a valid outcome measure of dialysis clearance in children undergoing peritoneal dialysis? Perit. Dial. Int. 21 (Suppl. 3), S179–S184 (2001).

    PubMed  Google Scholar 

  68. Fine, R. N., Attie, K. M., Kuntze, J., Brown, D. F. & Kohaut, E. C. for the Genentech Collaborative Study Group. Recombinant human growth hormone in infants and young children with chronic renal insufficiency. Pediatr. Nephrol. 9, 451–457 (1995).

    Article  CAS  Google Scholar 

  69. Mencarelli, F. et al. Growth hormone treatment started in the first year of life in infants with chronic renal failure. Pediatr. Nephrol. 24, 1039–1046 (2009).

    Article  Google Scholar 

  70. Schaefer, F., Klaus, G. & Mehls, O. the Mid-European Pediatric Peritoneal Dialysis Study Group. Peritoneal transport properties and dialysis dose affect growth and nutritional status in children on chronic peritoneal dialysis. J. Am. Soc. Nephrol. 10, 1786–1792 (1999).

    CAS  PubMed  Google Scholar 

  71. Denson, L. A. et al. Interleukin-6 inhibits hepatic growth hormone signaling via upregulation of Cis and Socs-3. Am. J. Physiol. Gastrointest. Liver Physiol. 284, G646–G654 (2003).

    Article  CAS  Google Scholar 

  72. Chavers, B. M., Li, S., Collins, A. J. & Herzog, C. A. Cardiovascular disease in pediatric chronic dialysis patients. Kidney Int. 62, 648–653 (2002).

    Article  Google Scholar 

  73. Parekh, R. S., Carroll, C. E., Wolfe, R. A. & Port, F. K. Cardiovascular mortality in children and young adults with end-stage kidney disease. J. Pediatr. 141, 191–197 (2002).

    Article  CAS  Google Scholar 

  74. Mitsnefes, M. M. Cardiovascular complications of pediatric chronic kidney disease. Pediatr. Nephrol. 23, 27–39 (2008).

    Article  Google Scholar 

  75. Wang, A. Y. et al. Inflammation, residual kidney function, and cardiac hypertrophy are interrelated and combine adversely to enhance mortality and cardiovascular death risk of peritoneal dialysis patients. J. Am. Soc. Nephrol. 15, 2186–2194 (2004).

    Article  CAS  Google Scholar 

  76. Bakkaloglu, S. A. et al. Assessment of cardiovascular risk in paediatric peritoneal dialysis patients: a Turkish Pediatric Peritoneal Dialysis Study Group (TUPEPD) report. Nephrol. Dial. Transplant. 24, 3525–3532 (2009).

    Article  Google Scholar 

  77. Kramer, A. M. et al. Demographics of blood pressure and hypertension in children on renal replacement therapy in Europe. Kidney Int. http://dx.doi.org/10.1038/ki.2011.232.

  78. Mitsnefes, M. & Stablein, D. Hypertension in pediatric patients on long-term dialysis: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). Am. J. Kidney Dis. 45, 309–315 (2005).

    Article  Google Scholar 

  79. Hölttä, T., Happonen, J. M., Rönnholm, K., Fyhrquist, F. & Holmberg, C. Hypertension, cardiac state, and the role of volume overload during peritoneal dialysis. Pediatr. Nephrol. 16, 324–331 (2001).

    Article  Google Scholar 

  80. Bakkaloglu, S. A. et al. for the International Pediatric Peritoneal Dialysis Network. Cardiac geometry in children receiving chronic peritoneal dialysis: findings from the International Pediatric Peritoneal Dialysis Network (IPPN) Registry. Clin. J. Am. Soc. Nephrol. 6, 1926–1933 (2011).

    Article  Google Scholar 

  81. Borzych, D. et al. for the International Pediatric PD Network (IPPN). Defining left ventricular hypertrophy in children on peritoneal dialysis. Clin. J. Am. Soc. Nephrol. 6, 1934–1943 (2011).

    Article  Google Scholar 

  82. Mitsnefes, M. M. et al. Severe left ventricular hypertrophy in pediatric dialysis: prevalence and predictors. Pediatr. Nephrol. 14, 898–902 (2000).

    Article  CAS  Google Scholar 

  83. Bakkaloglu, S. A. et al. Impact of peritoneal transport characteristics on cardiac function in paediatric peritoneal dialysis patients: a Turkish Pediatric Peritoneal Dialysis Study Group (TUPEPD) report. Nephrol. Dial. Transplant. 25, 2296–2303 (2010).

    Article  Google Scholar 

  84. Urbina, E. M. et al. Effect of body size, ponderosity, and blood pressure on left ventricular growth in children and young adults in the Bogalusa Heart Study. Circulation 91, 2400–2406 (1995).

    Article  CAS  Google Scholar 

  85. Mitsnefes, M. M. et al. Cardiac and vascular adaptation in pediatric patients with chronic kidney disease: role of calcium-phosphorus metabolism. J. Am. Soc. Nephrol. 16, 2796–2803 (2005).

    Article  CAS  Google Scholar 

  86. Matteucci, M. C. et al. for the ESCAPE Trial Group. Left ventricular geometry in children with mild to moderate chronic renal insufficiency. J. Am. Soc. Nephrol. 17, 218–226 (2006).

    Article  Google Scholar 

  87. Schlüter, K. D. & Piper, H. M. Trophic effects of catecholamines and parathyroid hormone on adult ventricular cardiomyocytes. Am. J. Physiol. 263, H1739–H1746 (1992).

    PubMed  Google Scholar 

  88. Amann, K., Ritz, E., Wiest, G., Klaus, G. & Mall, G. A role of parathyroid hormone for the activation of cardiac fibroblasts in uremia. J. Am. Soc. Nephrol. 4, 1814–1819 (1994).

    CAS  PubMed  Google Scholar 

  89. Piovesan, A. et al. Left ventricular hypertrophy in primary hyperparathyroidism. Effects of successful parathyroidectomy. Clin. Endocrinol. (Oxf.) 50, 321–328 (1999).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Contributions

F. Schaefer and B. A. Warady contributed equally to discussion of content for the article, researching data to include in the manuscript and reviewing and editing of the manuscript before submission.

Corresponding author

Correspondence to Franz Schaefer.

Ethics declarations

Competing interests

F. Schaefer has received a grant/research support from Fresenius Medical Care. B. A. Warady has received a grant/research support from Baxter Healthcare.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schaefer, F., Warady, B. Peritoneal dialysis in children with end-stage renal disease. Nat Rev Nephrol 7, 659–668 (2011). https://doi.org/10.1038/nrneph.2011.135

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrneph.2011.135

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing